# A Comparative Study of the Treatment of Real-world Patients With Clear Cell Carcinoma of the Ovary

> **NCT06279104** · — · RECRUITING · sponsor: **Tongji Hospital** · enrollment: 150 (estimated)

## Conditions studied

- Ovarian Clear Cell Carcinoma

## Interventions

- **DRUG:** physician's choice of chemotherapy
- **DRUG:** immune checkpoint inhibitor based therapy

## Key facts

- **NCT ID:** NCT06279104
- **Lead sponsor:** Tongji Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2023-03-01
- **Primary completion:** 2025-05-01
- **Final completion:** 2025-05-01
- **Target enrollment:** 150 (ESTIMATED)
- **Last updated:** 2024-08-13

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06279104

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06279104, "A Comparative Study of the Treatment of Real-world Patients With Clear Cell Carcinoma of the Ovary". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06279104. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*